Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Aprea ab – product pipeline review – 2012


Published on

2012 || Aprea AB – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

Aprea ab – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Aprea AB – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Aprea AB - Product Pipeline Review- 2012” provides data on the Aprea AB’s research and development focus. Thereport includes information on current developmental pipeline, complete with latestupdates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Aprea AB’s corporate website, SEC filings, investorpresentations and featured press releases, both from Aprea AB and industry-specificthird party sources, put together by Global Markets Direct’s team.Scope- Aprea AB - Brief Aprea AB overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Aprea AB human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
  2. 2. Table of contents:List of Tables 4List of Figures 4Aprea AB Snapshot 5Aprea AB Overview 5Key Information 5Key Facts 5Aprea AB – Research and Development Overview 6Key Therapeutic Areas 6Aprea AB – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Aprea AB – Pipeline Products Glance 10Aprea AB Clinical Stage Pipeline Products 10Phase I Products/Combination Treatment Modalities 10Aprea AB – Early Stage Pipeline Products 11Discovery Products/Combination Treatment Modalities 11Aprea AB – Drug Profiles 12APR-246 12Product Description 12Mechanism of Action 12R&D Progress 12RITA Program 13Product Description 13Mechanism of Action 13R&D Progress 13Wrap53 14Product Description 14Mechanism of Action 14R&D Progress 14Aprea AB – Pipeline Analysis 15Aprea AB – Pipeline Products by Therapeutic Class 15Aprea AB – Pipeline Products By Target 16Aprea AB – Pipeline Products by Route of Administration 17Aprea AB – Pipeline Products By Mechanism of Action 18Aprea AB – Recent Pipeline Updates 19
  3. 3. List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012BIOALVO S.A. – Product Pipeline Review – 2012Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cardio3 BioSciences SA – Product Pipeline Review – 2012Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012iCo Therapeutics Inc. – Product Pipeline Review – 2012Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012Mersana Therapeutics, Inc. – Product Pipeline Review – 2012Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012
  4. 4. Nuon Therapeutics, Inc. – Product Pipeline Review – 2012Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012ProStrakan Group plc – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: